{"transactions":[{"id":725613,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T21:44:27.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan (the \"Plan\"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 19,000 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2027, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":19000,"derivative":{"exercise_price":14.19,"expiration_date":"2036-06-25","underlying":"Class A Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001628280-26-045839","document":"wk-form4_1782510265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000162828026045839/wk-form4_1782510265.xml","form_type":"4"}},{"id":825309,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Common Stock","published_at":"2026-03-30T12:46:58.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":28089,"price":8.9505,"value":251410.5945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 28,089 shares purchased in the price range of $8.80 to $9.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":77289,"source":{"system":"sec-edgar","filing":"0001713795-26-000004","document":"wk-form4_1774874815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000171379526000004/wk-form4_1774874815.xml","form_type":"4"}},{"id":946963,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:21:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":358100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean January 2, 2026."}],"balance_after":358100,"derivative":{"exercise_price":16,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":358100},"source":{"system":"sec-edgar","filing":"0001713795-26-000002","document":"wk-form4_1767734492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000171379526000002/wk-form4_1767734492.xml","form_type":"4"}},{"id":989868,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-24T21:10:07.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."}],"balance_after":13500,"derivative":{"exercise_price":1,"expiration_date":"2035-11-19","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-25-115414","document":"tm2532045-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465925115414/tm2532045-6_4seq1.xml","form_type":"4"}},{"id":1101140,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T21:47:53.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan (the \"Plan\"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":14750,"derivative":{"exercise_price":4.01,"expiration_date":"2035-06-25","underlying":"Class A Common Stock","underlying_shares":14750},"source":{"system":"sec-edgar","filing":"0001437749-25-021372","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774925021372/rdgdoc.xml","form_type":"4"}},{"id":1217564,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T23:10:43.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the \"2020 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the  2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 8, 2021."}],"balance_after":337906,"derivative":{"exercise_price":1.04,"expiration_date":"2031-03-07","underlying":"Common Stock","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001815776-25-000011","document":"wk-form4_1741389036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000011/wk-form4_1741389036.xml","form_type":"4"}},{"id":1217563,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Common Stock","published_at":"2025-03-07T23:10:43.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":4200,"price":1.04,"value":4368.0,"ownership":{"direct":true},"balance_after":49200,"source":{"system":"sec-edgar","filing":"0001815776-25-000011","document":"wk-form4_1741389036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000011/wk-form4_1741389036.xml","form_type":"4"}},{"id":1304367,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T22:20:45.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":279100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean January 9, 2025."}],"balance_after":279100,"derivative":{"exercise_price":26.34,"expiration_date":"2035-01-08","underlying":"Common Stock","underlying_shares":279100},"source":{"system":"sec-edgar","filing":"0001815776-25-000003","document":"wk-form4_1736806836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000003/wk-form4_1736806836.xml","form_type":"4"}},{"id":1352561,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T21:33:25.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-20","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001104659-24-122593","document":"tm2429436-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465924122593/tm2429436-5_4seq1.xml","form_type":"4"}},{"id":1449982,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-24T00:16:36.000Z","date":"2024-07-22","kind":"exercise","planned":false,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the \"2020 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the  2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 8, 2021."}],"balance_after":342106,"derivative":{"exercise_price":1.04,"expiration_date":"2031-03-07","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001815776-24-000051","document":"wk-form4_1721780188.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000051/wk-form4_1721780188.xml","form_type":"4"}},{"id":1449981,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Common Stock","published_at":"2024-07-24T00:16:36.000Z","date":"2024-07-22","kind":"exercise","planned":false,"acquired":true,"shares":45000,"price":1.04,"value":46800.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001815776-24-000051","document":"wk-form4_1721780188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000051/wk-form4_1721780188.xml","form_type":"4"}},{"id":1499280,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T21:53:13.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":29500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on April 5, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":29500,"derivative":{"exercise_price":15.76,"expiration_date":"2034-05-23","underlying":"Class A Common Stock","underlying_shares":29500},"source":{"system":"sec-edgar","filing":"0001437749-24-018618","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924018618/rdgdoc.xml","form_type":"4"}},{"id":1561962,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:32:25.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 21, 2024."}],"balance_after":475000,"derivative":{"exercise_price":15.05,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001815776-24-000020","document":"wk-form4_1711413134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000020/wk-form4_1711413134.xml","form_type":"4"}},{"id":1561961,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:32:25.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":315864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 6, 2023."}],"balance_after":315864,"derivative":{"exercise_price":6.04,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":315864},"source":{"system":"sec-edgar","filing":"0001815776-24-000020","document":"wk-form4_1711413134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000020/wk-form4_1711413134.xml","form_type":"4"}},{"id":1561960,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:32:25.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":82723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 8, 2021."}],"balance_after":82723,"derivative":{"exercise_price":5.05,"expiration_date":"2032-11-23","underlying":"Common Stock","underlying_shares":82723},"source":{"system":"sec-edgar","filing":"0001815776-24-000020","document":"wk-form4_1711413134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000020/wk-form4_1711413134.xml","form_type":"4"}},{"id":1561959,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:32:25.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":387106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 8, 2021."}],"balance_after":387106,"derivative":{"exercise_price":1.04,"expiration_date":"2031-03-07","underlying":"Common Stock","underlying_shares":387106},"source":{"system":"sec-edgar","filing":"0001815776-24-000020","document":"wk-form4_1711413134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000020/wk-form4_1711413134.xml","form_type":"4"}},{"id":2475333,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-14T00:09:58.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":109000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."}],"balance_after":109000,"derivative":{"exercise_price":0.6938,"exercise_date":"2022-01-09","expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":109000},"source":{"system":"sec-edgar","filing":"0001104659-21-149236","document":"tm2135158-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465921149236/tm2135158-2_4seq1.xml","form_type":"4"}},{"id":2675491,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-06-09T21:19:46.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."}],"balance_after":100000,"derivative":{"exercise_price":1.41,"exercise_date":"2021-07-07","expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-078869","document":"tm2119289d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465921078869/tm2119289d1_4.xml","form_type":"4"}},{"id":3013150,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":313710,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, each option with an exercise price equal to or less than the Cash Portion that remains outstanding as of immediately prior to the Effective Time, whether vested or unvested, will be cancelled and converted into a right to receive, with respect to each share of Issuer Common stock subject to such option, an amount in cash, without interest, equal to the excess, if any, of (i) the Cash Portion over the per share exercise price of such option, plus (ii) the CVR Portion (the \"Option Consideration\"). All Option Consideration will be paid without interest and less any applicable tax withholdings"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2016 Inducement Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean August 3, 2017."}],"balance_after":0,"derivative":{"exercise_price":3.52,"expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":313710},"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3013149,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, each option with an exercise price equal to or less than the Cash Portion that remains outstanding as of immediately prior to the Effective Time, whether vested or unvested, will be cancelled and converted into a right to receive, with respect to each share of Issuer Common stock subject to such option, an amount in cash, without interest, equal to the excess, if any, of (i) the Cash Portion over the per share exercise price of such option, plus (ii) the CVR Portion (the \"Option Consideration\"). All Option Consideration will be paid without interest and less any applicable tax withholdings"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Twenty five percent (25%) of the shares subject to the Option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2020."}],"balance_after":0,"derivative":{"exercise_price":10.89,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3013148,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, each option with an exercise price equal to or less than the Cash Portion that remains outstanding as of immediately prior to the Effective Time, whether vested or unvested, will be cancelled and converted into a right to receive, with respect to each share of Issuer Common stock subject to such option, an amount in cash, without interest, equal to the excess, if any, of (i) the Cash Portion over the per share exercise price of such option, plus (ii) the CVR Portion (the \"Option Consideration\"). All Option Consideration will be paid without interest and less any applicable tax withholdings"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Twenty five percent (25%) of the shares subject to the Option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":3.9,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3013147,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":195062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, each option with an exercise price equal to or less than the Cash Portion that remains outstanding as of immediately prior to the Effective Time, whether vested or unvested, will be cancelled and converted into a right to receive, with respect to each share of Issuer Common stock subject to such option, an amount in cash, without interest, equal to the excess, if any, of (i) the Cash Portion over the per share exercise price of such option, plus (ii) the CVR Portion (the \"Option Consideration\"). All Option Consideration will be paid without interest and less any applicable tax withholdings"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":3.38,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":195062},"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3013146,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":36290,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, each option with an exercise price equal to or less than the Cash Portion that remains outstanding as of immediately prior to the Effective Time, whether vested or unvested, will be cancelled and converted into a right to receive, with respect to each share of Issuer Common stock subject to such option, an amount in cash, without interest, equal to the excess, if any, of (i) the Cash Portion over the per share exercise price of such option, plus (ii) the CVR Portion (the \"Option Consideration\"). All Option Consideration will be paid without interest and less any applicable tax withholdings"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the   Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean August 3, 2017."}],"balance_after":0,"derivative":{"exercise_price":3.52,"expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":36290},"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3013145,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":10000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the terms and subject to the conditions set forth in the Agreement and Plan of Merger, dated August 10, 2020 (the \"Merger Agreement\"), by and among Ligand Pharmaceutical Incorporated, a Delaware corporation, Pelican Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent, and the Issuer, each issued and outstanding share of Issuer common stock (other than (A) Cancelled Shares, (B) Accepted Company Shares, and (C) Dissenting Company Shares (each as defined in the Merger Agreement)) was automatically converted into the right to receive (i) $12.00 per share, net to the holder thereof, subject to reduction for any applicable withholding Taxes (as defined in the Merger Agreement) payable in respect thereof, in cash (the \"Cash Portion\"), and (ii) a non-transferrable contractual contingent value right per share (a \"CVR\"), pursuant to the Contingent Value Rights Agreement,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from footnote 1) dated as of September 30, 2020 (as it may be amended from time to time, the \"CVR Agreement\"), to receive a contingent payment of $2.00 in cash upon the achievement of a specified milestone as set forth in the CVR Agreement (the \"CVR Portion\"), effective immediately prior to the Effective Time (as defined in the Merger Agreement)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the Schimmelpennink-Van Alphen Trust, dated 7/31/2019, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3013144,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-05T20:30:11.000Z","date":"2020-10-01","kind":"other","acquired":false,"shares":16658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the terms and subject to the conditions set forth in the Agreement and Plan of Merger, dated August 10, 2020 (the \"Merger Agreement\"), by and among Ligand Pharmaceutical Incorporated, a Delaware corporation, Pelican Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent, and the Issuer, each issued and outstanding share of Issuer common stock (other than (A) Cancelled Shares, (B) Accepted Company Shares, and (C) Dissenting Company Shares (each as defined in the Merger Agreement)) was automatically converted into the right to receive (i) $12.00 per share, net to the holder thereof, subject to reduction for any applicable withholding Taxes (as defined in the Merger Agreement) payable in respect thereof, in cash (the \"Cash Portion\"), and (ii) a non-transferrable contractual contingent value right per share (a \"CVR\"), pursuant to the Contingent Value Rights Agreement,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from footnote 1) dated as of September 30, 2020 (as it may be amended from time to time, the \"CVR Agreement\"), to receive a contingent payment of $2.00 in cash upon the achievement of a specified milestone as set forth in the CVR Agreement (the \"CVR Portion\"), effective immediately prior to the Effective Time (as defined in the Merger Agreement)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-027411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320027411/doc4.xml","form_type":"4"}},{"id":3294869,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-03T20:10:58.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the Option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2020."}],"balance_after":225000,"derivative":{"exercise_price":10.89,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-20-002634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924320002634/doc4.xml","form_type":"4"}},{"id":3677404,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-04T17:40:43.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the Option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2019."}],"balance_after":300000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-19-002485","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924319002485/doc4.xml","form_type":"4"}},{"id":3816994,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-13T16:25:26.000Z","date":"2018-09-11","kind":"purchase","acquired":true,"shares":500,"price":5.01,"value":2505.0,"ownership":{"direct":true},"balance_after":26658,"source":{"system":"sec-edgar","filing":"0000899243-18-024433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924318024433/doc4.xml","form_type":"4"}},{"id":3816993,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-13T16:25:26.000Z","date":"2018-09-11","kind":"purchase","acquired":true,"shares":9500,"price":5.04,"value":47880.0,"ownership":{"direct":true},"balance_after":26158,"source":{"system":"sec-edgar","filing":"0000899243-18-024433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924318024433/doc4.xml","form_type":"4"}},{"id":4079165,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-02T20:07:33.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":195062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean February 1, 2018."}],"balance_after":195062,"derivative":{"exercise_price":3.38,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":195062},"source":{"system":"sec-edgar","filing":"0000899243-18-002751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924318002751/doc4.xml","form_type":"4"}},{"id":4079164,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:07:33.000Z","date":"2018-02-01","kind":"tax_withholding","acquired":false,"shares":11236,"price":3.38,"value":37977.68,"ownership":{"direct":true},"balance_after":16658,"source":{"system":"sec-edgar","filing":"0000899243-18-002751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924318002751/doc4.xml","form_type":"4"}},{"id":4079163,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:07:33.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":27894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units pursuant to the Issuer's 2014 Equity Incentive Plan.  Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on the February 1, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units pursuant to the Issuer's 2014 Equity Incentive Plan.  Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on the February 1, 2018."}],"balance_after":27894,"source":{"system":"sec-edgar","filing":"0000899243-18-002751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924318002751/doc4.xml","form_type":"4"}},{"id":4219678,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-01T17:06:30.000Z","date":"2017-09-01","kind":"grant","acquired":true,"shares":36290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2014 Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean August 3, 2017."}],"balance_after":36290,"derivative":{"exercise_price":3.52,"expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":36290},"source":{"system":"sec-edgar","filing":"0000899243-17-021367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924317021367/doc4.xml","form_type":"4"}},{"id":4219677,"issuer":{"id":146052,"kind":"organization","name":"Pfenex Inc.","symbol":"PFNX"},"owners":[{"id":35188,"kind":"person","name":"Schimmelpennink Evert B.","position":1,"cik":"0001713795","reported_name":"Schimmelpennink Evert B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-01T17:06:30.000Z","date":"2017-09-01","kind":"grant","acquired":true,"shares":313710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest every month thereafter such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider (as such term is defined in the Issuer's 2016 Inducement  Equity Incentive Plan) through each such date. \"Vesting Commencement Date\" shall mean August 3, 2017."}],"balance_after":313710,"derivative":{"exercise_price":3.52,"expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":313710},"source":{"system":"sec-edgar","filing":"0000899243-17-021367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478121/000089924317021367/doc4.xml","form_type":"4"}}]}